Transdermal Oxybutynin for Overactive Bladder-Reference-Cited by-同舟云学术

Transdermal Oxybutynin for Overactive Bladder

Published:2006-11 Issue:4 Volume:33 Page:455-463
ISSN:0094-0143
Container-title:Urologic Clinics of North America
language:en
Short-container-title:Urologic Clinics of North America

Author:

Davila G. Willy,Starkman Jonathan S.,Dmochowski Roger R.

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Direct measurement of the anticholinergic activity of a series of pharmacological compounds on the canine and rabbit urinary bladder;Levin;J Urol,1982

2. R and S enantiomers of oxybutynin: pharmacological effects in guinea pig bladder and intestine;Kachur;J Pharmacol Exp Ther,1988

3. Identification and characterization of muscarinic cholinergic receptors in the human urinary bladder and parotid gland;Batra;J Auton Nerv Syst,1987

4. Tolterodine: a new bladder-selective antimuscarinic agent;Nilvebrant;Eur J Pharmacol,1997

5. Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins;Wang;J Pharmacol Exp Ther,1995

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosing Variability and Clinical Outcomes of Oxybutynin: A Pediatric Cohort of Patients With Neurogenic Bladder;Topics in Spinal Cord Injury Rehabilitation;2022-06-01

2. Current pharmacotherapy of overactive bladder;International braz j urol;2021-12

3. Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review;Pharmaceuticals;2021-04-26

4. Individualizing Drug Therapy;Contemporary Pharmacotherapy of Overactive Bladder;2018-09-26

5. Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?;Advances in Urology;2018-07-29